Received Apr 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) | SANOFI PASTEUR | UNK | — | — |
Flu; Initial information received on 09-Mar-2026 regarding an unsolicited valid non-serious case received from a nurse. This case involves a patient of unknown age and unknown gender who experienced flu after receiving INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (Fluzone HD). The patient's past medical history, medical treatment(s), vaccination(s), and family history were not provided. On an unknown date, the patient received an unknown dose and unknown frequency of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE] suspension for injection (batch and expiry: unknown) (strength: unknown) via unknown route in an unknown administration site for prophylactic vaccination (Immunisation). The patient experienced flu for a week (Influenza, onset: unknown, latency: unknown). Action taken: not applicable. Corrective treatment: not reported. Event outcome: unknown for influenza.
Comments: NONE